among women with cosmetic breast implants and found no association with breast cancer risk [6, 7] . However, the issues of breast cancer detec tion and breast cancer survival when using these devices have been studied less.
The amount of parenchymal breast tissue obscured at mammography by the implant is known to be between 22 and 83% [8] . This can be explained by several mechanisms. For instance, the visualization of breast tissue can be impaired by an insufficient compression of the breast in the presence of breast implants. Implantrelated artifacts can also be observed on the imagery which can increase the difficulty in interpreting mammograms among women with breast implants [1, 9] . In fact, the presence of breast implants increases the falsenegative rate (poorer sensitivity) of mammograms compared with nonaugmented breasts, but does not increase the falsepositive rate (poorer specificity) [10] . Spe cialized radiographic techniques have been devel oped for women with breast implants to improve visualization of the breast tissue. This is done by bringing breast tissue over and in front of the implant and by pushing the implant against the chest wall [11, 12] . Even when using these special ized techniques, a third of the breast tissue can not be properly visualized [1] . It has also been shown that capsular contracture, a scar tissue that develops in response to the foreign object around breast tissue, which is seen in approxi mately 15-20% of augmented women can reduce mammographic sensitivity by 30-50% [4] .
A recent systematic review and meta analysis conducted by our group showed a tendency towards later stage of breast cancer at diagnosis among women with cosmetic breast implants [13] . Moreover, breast cancerrelated survival following the diagnosis of such disease was also investigated given that the possible diagnosis of advanced tumors could translate into poorer sur vival. We found that cosmetic breast implants seem to adversely affect breast cancerspecific sur vival following the diagnosis of such disease [13] .
Cosmetic breast augmentation is the most com monly performed cosmetic procedure in the USA [101] . Although cosmetic breast implants are popular, these devices still raise some concerns because they are radiopaque at mammography, which can impair the visualization of breast tissue [1] . Consequently, the ability to detect breast cancer at an early stage may be affected by the presence of breast implants, which may subsequently affect breast cancer survival. One in eight US women will be diagnosed as hav ing breast cancer at some time in their lives [2] . Thus, it is reasonable to say that a number of women with cosmetic breast implants will go on to develop breast cancer. Therefore, it is important that women considering breast aug mentation surgery, and those who already have cosmetic breast implants, are informed of the issues related to the diagnosis and prognosis of breast cancer when using these devices.
Breast implants have been used since the early 1960s [3] . Also known as augmentation mamma plasty, breast implant surgery is an elective surgi cal procedure to enhance the size of a woman's breast by insertion of a mammary prosthesis behind each breast [4] . They are mainly used for cosmetic purposes, but also for breast recon struction in the case of a mastectomy. There are mainly two types of cosmetic breast implants; silicone gelfilled implants and salinefilled implants. Silicone gelfilled implants are made of a silicone elastomer shell of varying thickness that encases different volumes of silicone gel and oil. Salinefilled implants consist of a single lumen enclosed by a silicone elastomer envelope. These implants are inflated with sterile saline via a selfsealing valve through a closed system into the recipient [4] .
Since their first use over half a century ago, cosmetic breast implants have been subject to a number of controversies. For instance, con cerns over silicone as a potential carcinogen were raised in the 1980s [5] . Nevertheless, sev eral studies investigated longterm cancer risk future science group www.futuremedicine.com These findings of later breast cancer stage at diag nosis and lower breast cancer survival are impor tant; women with breast implants or consider ing having implants need to be informed of such findings. Moreover, recommendations regarding breast imaging in the presence of breast implants need to take these findings into account.
Furthermore, it has been suggested that specific breast implant characteristics might affect the detection of breast cancer to variable extents [14] . For instance, subglandular implant placement (i.e., implants placed under the breast glands) could obstruct the visualization of mammograms more than submuscular placement owing to its proximity with breast tissue [14, 15] . In fact, previ ous reports showed that subglandular placement may obscure 39-49% of breast tissue compared with 9-28% for submuscular implant placement [14, 15] . However, to date, the issues regarding the stage of breast cancer at diagnosis and breast cancer survival have not been separately clari fied for these two types of implant placement. Further studies need to be conducted to clarify these issues as they could affect recommendations to women and their physicians.
As the female population with breast implants increases and ages, the number of breast cancer cases diagnosed in this population will increase, and clinical concerns about the detection of these breast cancers and subsequent survival need to be addressed. Many women around the world have cosmetic breast implants and given their increas ing popularity, more women are expected to have breast augmentation for cosmetic purposes. Therefore, women considering such procedures, women who already have implants and physi cians and other health professionals who treat these women, should be informed of the issues regarding breast cancer diagnosis and prognosis in the presence of breast implants. Women with breast implants or considering having implants should discuss these important issues with their healthcare professionals.
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